Condition

Seasonal Allergic Rhinitis

ClinicalTrials.gov condition label

Clinical trials6

Recruiting1

Common interventions7

Lead sponsors shown5

Clinical trials

6 shown

Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA StudyNCT07055542 · 2025-08-27

Study of Grass-SPIRE in Subjects With Grass Allergies and AsthmaNCT02161107 · 2014-04-01

Safety Study of Ragweed-SPIRE in Subjects With Ragweed Allergies and AsthmaNCT02061670 · 2014-01-01

Montelukast as a Controller of Atopic SyndromeNCT00559546 · 2007-03-01

Adolescent and Adult Subjects With Asthma and Seasonal Allergic Rhinitis Receiving Advair Diskus or PlaceboNCT00385463 · 2006-04-01

The Role of Pollen Starch Granules in Pollen Challenge Studies in the Fraunhofer Environmental Exposure UnitNCT00209365 · 2005-09-01

Common interventions

PlaceboBIOLOGICAL2 Adding Advair Diskus 100/50mcg (FSC) BID and Singulair 10mg is added to placebo Diskus BIDDRUG1 exposure to grass pollen/starch granulesPROCEDURE1 Grass-SPIREBIOLOGICAL1 montelukastDRUG1 ObservationalDIAGNOSTIC_TEST1 Ragweed-SPIREBIOLOGICAL1

Leading sponsors

Circassia Limited2 Creighton University1 Fraunhofer-Institute of Toxicology and Experimental Medicine1 University of Helsinki1 University of Melbourne1

Trial status mix

COMPLETED4

RECRUITING1

WITHDRAWN1

Phase mix

NA3

PHASE22

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.